Ligand Pfizer Collaboration Extended (NASDAQ:LGND)

By: Stock Market News & Stocks to Watch from StraightStocks

Posted on November 06, 2009 at 10:30 AM EST

Ligand Pharmaceuticals Inc (NASDAQ:LGND) has announced that they have extended their research collaboration with Pfizer for JAK3 by one year. Both the companies had entered the research and license agreement in December 2006 with Wyeth ...

Related Stocks:

GlaxoSmithKline PLC ADS ProShares Ultra Semiconductors

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates